过去一年中添加的文章,按日期排序

Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant‐level pooled analysis from the CANVAS Program and CREDENCE …

M Vaduganathan, CP Cannon… - European Journal of …, 2024 - Wiley Online Library
14 天前 - … to cardiovascular risk in patients with type 2 diabetes mellitus and recent acute …
efficacy of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus

Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial

P Bernocchi, V Giudici, G Borghi, P Bertolaia, S D'Isa… - Trials, 2024 - Springer
50 天前 - … are prevalent public health issues in Europe. These complex … to assess the
effectiveness of a telemedicine program for managing heart failure and type 2 diabetes at home. The …

Optimal Duration of CPX-351 Treatment and Best Timing for Consolidation with Allogeneic Stem Cell Transplantation: Evidence from a Large Real-World Italian Study

F Guolo, L Fianchi, MP Martelli, P Chiusolo, F Lussana… - Blood, 2023 - Elsevier
225 天前 - … on the optimal duration of treatment with CPX-351 or the … the efficacy of CPX-351
among NPM1 or FLT3-ITD mutated AML or in patient with low risk AML according to European

Holistic Person-Centered Care for Individuals With Type 2 Diabetes Mellitus

HC Hsu, YJ Lee, RH Wang - Hu Li Za Zhi, 2023 - search.proquest.com
233 天前 - … An effective model of diabetes care and education: The … ican Diabetes Association
(ADA) and the European Asso… the chronic care model to construct a supportive healthcare

Effect of semaglutide on global longitudinal strain and global myocardial work efficiency in patients with uncontrolled type 2 diabetes mellitus and obesity

G Armentaro, V Cassano, D Crescibene… - European Heart …, 2023 - academic.oup.com
244 天前 - Type 2 Diabetes mellitus (T2DM) increases of two-to three-fold the risk of
cardiovascular disease (CVD). Cardiovascular outcome trials (CVOTs) demonstrated that glucagon-…

Newcard telemonitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the …

A Pathak, F Roubille, M Galinier, T Damy… - European Heart …, 2023 - academic.oup.com
244 天前 - … Especially, those data place telemonitoring of heart failure as a real improvement
in the care pathway which needs time to be effective but is able to have an effect even on the …

[引用][C] Insulin Management in Patients With Diabetes Receiving Hemodialysis: Unanswered Questions and Way Forward

RG McCoy, PJ O'Connor - American Journal of Kidney Diseases, 2024 - ajkd.org
253 天前 - … that confer greater cardiovascular and kidney benefits, less harm from hypoglycemia
type 2 diabetes receiving hemodialysis at a network of 288 dialysis facilities in 7 European

[引用][C] miR‐21p‐5p coordinates biological pathways to promote MASLD progression

P Aspichueta, MB Zeisel - Liver International, 2023 - Wiley Online Library
267 天前 - … The limited efficacy of current and emerging therapies for fatty​ liver​ disease​ is​
… ​ will​ contribute to discover novel effective therapeutic approaches. In the last decade, a …

… COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC …

A Cote, KJA Johnston, C Seah, H Young… - European …, 2023 - Elsevier
283 天前 - … cost-effective alternative to drug discovery for the pharmaceutical treatment of complex
… Interim findings highlight new genetically-informed avenues for drug treatment of chronic